Tumors from the other two patients with RAD51D pathogenic variants, c.556C > T; p.(Arg186*) and c.801delC; p.(Trp268Glyfs*42), harboring longer RAD51D gene products, were also negative for HRD. The gene discussed is RAD51D; the disease is hypoparathyroidism-retardation-dysmorphism syndrome.